Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001654954-17-011501
Filing Date
2017-12-11
Accepted
2017-12-11 16:40:43
Documents
53
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 OF FORM 10-Q cvm_10qa.htm 10-Q/A 996129
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF cvm_ex31.htm EX-31 29361
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE cvm_ex32.htm EX-32 9644
  Complete submission text file 0001654954-17-011501.txt   3666368

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cvm-20170630.xml EX-101.INS 681915
5 XBRL TAXONOMY EXTENSION SCHEMA cvm-20170630.xsd EX-101.SCH 48332
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cvm-20170630_cal.xml EX-101.CAL 41643
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cvm-20170630_def.xml EX-101.DEF 53839
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvm-20170630_lab.xml EX-101.LAB 257472
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvm-20170630_pre.xml EX-101.PRE 173467
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 001-11889 | Film No.: 171249898
SIC: 2836 Biological Products, (No Diagnostic Substances)